NKTP Share Price Performance
US$0
0.00 (0.00%)
Price US$0
Share Pricen/a
No trending discussion available.
No recently updated narratives available.
NÖK Therapeutics, Inc. operates as a biotechnology company that develops autologous natural killer (NK) cell therapies. It provides cell therapies, bispecific antibodies, checkpoint inhibitors, severe toxicity profiles, autologous, non-engineered, lymphodepletion, dosing and outpatient infusions. The company was incorporated in 2024 and is based in Cranberry Township, Pennsylvania.